COVID-19 and the health of people who use drugs: What is and what could be?


Journal

The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 20 11 2020
Statut: ppublish

Résumé

SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know it, and continues to do so. How COVID-19 affects people who use drugs, the environments in which they live, and capacities of response, warrants immediate attention. This special issue begins to map how COVID-19 is altering the health of people who use drugs, including in relation to patterns of drug use, service responses, harms that may relate to drug use, interventions to reduce risk of harms, COVID-19 health, and drug policies. We emphasise the need to envisage COVID-19 and its effects as a matter of intersecting 'complex adaptive systems': that is, the impacts of COVID-19 extend beyond the virus and related illness conditions to encompass multiple social, cultural, economic, policy and political effects; and these affect the health of people who use drugs directly as well as indirectly by altering the risk and enabling environments in which they live. We synthesize emergent evidence on the impact of COVID-19 on the health of people who use drugs. A key concern we identify is how to sustain policy and service delivery improvements prompted by COVID-19. We need to maintain an ethos of emergent adaptation and experimentation towards the creation of safer environments in relation to the health of people who use drugs.

Identifiants

pubmed: 33183679
pii: S0955-3959(20)30296-6
doi: 10.1016/j.drugpo.2020.102958
pmc: PMC7837052
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102958

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Int J Drug Policy. 2017 Aug;46:156-159
pubmed: 28735773
J Subst Abuse Treat. 2020 Oct;117:108061
pubmed: 32811622
Int J Drug Policy. 2011 Sep;22(5):326-34
pubmed: 21855312
Clin Infect Dis. 2020 Aug 03;:
pubmed: 32744615
J Int AIDS Soc. 2020 May;23(5):e25503
pubmed: 32378345
PLoS Med. 2020 Jun 30;17(6):e1003266
pubmed: 32603323
Drugs. 2019 Sep;79(13):1395-1418
pubmed: 31352603
J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):475-482
pubmed: 33136748
Int J Drug Policy. 2011 Sep;22(5):321-5
pubmed: 21840195
Int J Drug Policy. 2011 Sep;22(5):353-9
pubmed: 21555212
Lancet. 2019 Oct 26;394(10208):1580-1590
pubmed: 31657733
AIDS Behav. 2016 Jan;20(1):85-97
pubmed: 26050155
Respir Med. 2020 Sep;171:106096
pubmed: 32763754
Indian J Psychiatry. 2020 May-Jun;62(3):322-326
pubmed: 32773878
Int J Drug Policy. 2020 Sep;83:102835
pubmed: 32690405
Int J Drug Policy. 2020 Sep;83:102830
pubmed: 32646714
Int J Drug Policy. 2020 Sep;83:102821
pubmed: 32591222
Public Health Rep. 2020 Jul/Aug;135(4):435-441
pubmed: 32516035
Int J Drug Policy. 2020 Aug 15;:102905
pubmed: 32811685
JAMA Netw Open. 2020 Apr 1;3(4):e202361
pubmed: 32271389
Soc Anthropol. 2020 May 20;:
pubmed: 32836970
Int J Drug Policy. 2020 Sep;83:102819
pubmed: 32560975
Drug Alcohol Depend. 2020 Sep 1;214:108176
pubmed: 32717504
Drug Alcohol Rev. 2020 May;39(4):297-300
pubmed: 32445265
Int J Drug Policy. 2020 Sep;83:102896
pubmed: 32768156
Drug Alcohol Depend. 2018 Aug 1;189:1-7
pubmed: 29857327
Int J Drug Policy. 2020 Sep;83:102834
pubmed: 32646713
Subst Use Misuse. 2015;50(8-9):1188-94
pubmed: 25775311
Pain Med. 2016 Jan;17(1):85-98
pubmed: 26333030
PLoS One. 2020 Apr 27;15(4):e0232218
pubmed: 32339212
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Sociol Health Illn. 2014 Feb;36(2):239-51
pubmed: 24528305
Int J Drug Policy. 2013 May;24(3):167-72
pubmed: 23352332
Lancet. 2019 Nov 2;394(10209):1668-1684
pubmed: 31668410
Soc Sci Med. 2019 Oct;238:112488
pubmed: 31422173
Soc Sci Med. 2019 Aug;234:112384
pubmed: 31254965
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):369-76
pubmed: 18176320
J Public Health (Oxf). 2016 Sep;38(3):e301-e308
pubmed: 26491067
Int J Drug Policy. 2020 Sep;83:102895
pubmed: 32741718
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
Int J Drug Policy. 2020 Sep;83:102894
pubmed: 32741717
Int J Drug Policy. 2018 Jul;57:104-110
pubmed: 29715589
N Engl J Med. 2020 May 28;382(22):2075-2077
pubmed: 32240582
AIDS Behav. 2020 Jul;24(7):2003-2006
pubmed: 32266502
Addiction. 2020 Jul;115(7):1295-1305
pubmed: 31860767
AIDS Behav. 2020 Sep;24(9):2466-2468
pubmed: 32333209
Chest. 2019 Feb;155(2):279-287
pubmed: 30189189
Int J Drug Policy. 2009 May;20(3):193-201
pubmed: 19147339
Soc Sci Med. 2014 Mar;105:59-66
pubmed: 24508718
Drug Alcohol Rev. 2002 Sep;21(3):295-303
pubmed: 12270082
Drug Alcohol Depend. 2017 Feb 01;171:39-49
pubmed: 28013096
J Addict Med. 2020 Jul/Aug;14(4):e8-e9
pubmed: 32404652
Int J Drug Policy. 2020 Sep;83:102901
pubmed: 32807624
Lancet Infect Dis. 2020 Jul;20(7):782
pubmed: 32592670
Harm Reduct J. 2020 Jul 17;17(1):49
pubmed: 32680520
Int J Drug Policy. 2020 Sep;83:102870
pubmed: 32741719
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):523-526
pubmed: 32352954
J Ethn Subst Abuse. 2017 Oct-Dec;16(4):404-419
pubmed: 28306386
Int J Drug Policy. 2018 Jul;57:25-31
pubmed: 29660732
Addiction. 1999 Sep;94(9):1323-36
pubmed: 10615718
Int J Drug Policy. 2020 Nov;85:102607
pubmed: 31864787
S Afr Med J. 2020 Apr 30;110(6):12939
pubmed: 32880539
Lancet. 2019 Nov 2;394(10209):1652-1667
pubmed: 31668409
Harm Reduct J. 2010 May 25;7:11
pubmed: 20500870
Int J Drug Policy. 2020 Sep;83:102829
pubmed: 32595070
Int J Drug Policy. 2012 Jul;23(4):338-40
pubmed: 22280916
Addiction. 2010 Sep;105(9):1545-54
pubmed: 20579009
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Subst Abuse Treat. 2019 Sep;104:64-71
pubmed: 31370986
Drug Alcohol Rev. 2005 Mar;24(2):143-55
pubmed: 16076584
Harm Reduct J. 2020 May 6;17(1):26
pubmed: 32375887
Int J Drug Policy. 2020 Sep;83:102872
pubmed: 32713765
BMJ. 2009 Jun 16;338:b2225
pubmed: 19535400
Public Health Rep. 1999 Sep-Oct;114(5):439-47
pubmed: 10590766
BMJ. 2020 Apr 27;369:m1557
pubmed: 32341002
Int J Drug Policy. 2020 Sep;83:102806
pubmed: 32513622
Int J Drug Policy. 2016 Jan;27:43-55
pubmed: 26342272
Br J Anaesth. 2020 Sep;125(3):238-242
pubmed: 32731958
PLoS One. 2020 Aug 26;15(8):e0238215
pubmed: 32845926
BMJ. 2020 Jul 30;370:m2980
pubmed: 32732190
Psychol Bull. 2014 Jul;140(4):921-48
pubmed: 24547896
Patient Prefer Adherence. 2018 Oct 11;12:2123-2129
pubmed: 30349206
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):521-522
pubmed: 32352957
Int J Drug Policy. 2020 Sep;83:102880
pubmed: 32739148
J Urban Health. 2020 Aug;97(4):448-456
pubmed: 32720298
Int J Drug Policy. 2020 Nov;85:102727
pubmed: 32513621
Int J Drug Policy. 2019 Sep;71:183-188
pubmed: 30718120
Int J Drug Policy. 2009 May;20(3):283-91
pubmed: 19101131
PLoS Med. 2019 Nov 26;16(11):e1002965
pubmed: 31770388
Harm Reduct J. 2020 Aug 24;17(1):60
pubmed: 32831083
Harm Reduct J. 2014 Mar 04;11:10
pubmed: 24593319
Int J Environ Res Public Health. 2016 Jan 13;13(1):
pubmed: 26771628
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32565430
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S110-7
pubmed: 25978477
Int J Drug Policy. 2020 Sep;83:102832
pubmed: 32654930
BMC Med. 2018 Jun 20;16(1):95
pubmed: 29921272
Br Med Bull. 2020 Oct 14;135(1):38-49
pubmed: 32897357
Drug Alcohol Depend. 2014 Nov 1;144:274-8
pubmed: 25236889
Lancet. 2018 Jul 28;392(10144):312-358
pubmed: 30032975
Subst Use Misuse. 2020;55(6):861-870
pubmed: 31900021
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Addiction. 2013 Apr;108(4):659-67
pubmed: 23075121
Liver Int. 2020 Aug;40(8):2042
pubmed: 32319207
BMJ. 2015 Jun 10;350:h2698
pubmed: 26063215
Drug Alcohol Depend. 2018 Feb 1;183:96-101
pubmed: 29245104
Int J Drug Policy. 2020 Sep;83:102851
pubmed: 32736959
JAMA. 2020 Aug 11;324(6):602-603
pubmed: 32639537
Int J Drug Policy. 2020 Nov;85:102704
pubmed: 32173274
Lancet. 2017 Dec 9;390(10112):2602-2604
pubmed: 28622953
J Int AIDS Soc. 2020 Aug;23(8):e25587
pubmed: 32767707
Drug Alcohol Rev. 2019 Jul;38(5):510-518
pubmed: 31131514
Chest. 2020 Mar;157(3):558-565
pubmed: 31759961
Int J Soc Psychiatry. 2020 May 14;:20764020922890
pubmed: 32408789
Lancet. 2019 Oct 26;394(10208):1560-1579
pubmed: 31657732
Implement Sci. 2013 Feb 13;8:18
pubmed: 23406398
Int J Drug Policy. 2020 Sep;83:102902
pubmed: 32807625
Am J Public Health. 2008 Feb;98(2):221-30
pubmed: 18172144
J Hepatol. 2021 Jan;74(1):31-36
pubmed: 32777322
BMJ. 2018 Aug 29;362:k3207
pubmed: 30158106
J Int AIDS Soc. 2020 Jul;23(7):e25583
pubmed: 32697423

Auteurs

Jason Grebely (J)

The Kirby Institute, UNSW Sydney, Sydney, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.

Magdalena Cerdá (M)

Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, United States.

Tim Rhodes (T)

Centre for Social Research in Health, UNSW Sydney, Sydney, Australia; London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH